Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Apr. 30, 2021	Apr. 30, 2020
Operating activities
Net income (loss)	$ 5,255	$ (1,026)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	972	1,216
Stock-based compensation	488	397
Change in assets and liabilities:
Trade accounts receivable	(1,336)	198
Prepaid expenses and other current assets	171	259
Other assets	75	24
Trade accounts payable and accrued expenses	1,626	(37)
Deferred revenue	486	552
Net cash provided by operating activities	7,737	1,583
Investing activities
Capitalized software and technology development costs and purchase of equipment	(543)	(613)
Investment in private company	(50)
Net cash used in investing activities	(593)	(613)
Financing activities
Proceeds from sales of Class B Common Stock	12,355	2,250
Payment of issuance costs	(469)	(141)
Proceeds from PPP loan payable		218
Repayment of insurance premium loan payable	(161)	(125)
Proceeds from exercise of stock options	819	4
Purchase of treasury stock in connection with restricted stock and deferred stock units vesting	(26)	(29)
Net cash provided by financing activities	12,518	2,177
Effect of exchange rate changes on cash and cash equivalents	142	(126)
Net increase in cash and cash equivalents	19,804	3,021
Cash and cash equivalents at beginning of period	5,111	1,609
Cash and cash equivalents at end of period	24,915	4,630
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash payments made for income taxes	1	3
Cash payments made for interest expenses	2	1
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Note payable issued for insurance premium financing	$ 181